CN1083429C - 取代的烷基二胺衍生物和其作为速激肽拮抗剂的用途 - Google Patents

取代的烷基二胺衍生物和其作为速激肽拮抗剂的用途 Download PDF

Info

Publication number
CN1083429C
CN1083429C CN95193680A CN95193680A CN1083429C CN 1083429 C CN1083429 C CN 1083429C CN 95193680 A CN95193680 A CN 95193680A CN 95193680 A CN95193680 A CN 95193680A CN 1083429 C CN1083429 C CN 1083429C
Authority
CN
China
Prior art keywords
ethylamino
compound
methyl
benzyl
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95193680A
Other languages
English (en)
Chinese (zh)
Other versions
CN1155883A (zh
Inventor
T·P·布勒克霍德
E·库德拉茨
T-B李
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of CN1155883A publication Critical patent/CN1155883A/zh
Application granted granted Critical
Publication of CN1083429C publication Critical patent/CN1083429C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the nitrogen atom of at least one of the carboxamide groups further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
CN95193680A 1994-06-20 1995-05-19 取代的烷基二胺衍生物和其作为速激肽拮抗剂的用途 Expired - Fee Related CN1083429C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/262,209 US5597845A (en) 1994-06-20 1994-06-20 Substituted alkyldiamine derivatives
US08/262,209 1994-06-20

Publications (2)

Publication Number Publication Date
CN1155883A CN1155883A (zh) 1997-07-30
CN1083429C true CN1083429C (zh) 2002-04-24

Family

ID=22996631

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95193680A Expired - Fee Related CN1083429C (zh) 1994-06-20 1995-05-19 取代的烷基二胺衍生物和其作为速激肽拮抗剂的用途

Country Status (20)

Country Link
US (1) US5597845A (cg-RX-API-DMAC7.html)
EP (1) EP0767783B1 (cg-RX-API-DMAC7.html)
JP (1) JP3920916B2 (cg-RX-API-DMAC7.html)
KR (1) KR100371981B1 (cg-RX-API-DMAC7.html)
CN (1) CN1083429C (cg-RX-API-DMAC7.html)
AT (1) ATE169905T1 (cg-RX-API-DMAC7.html)
AU (1) AU691619B2 (cg-RX-API-DMAC7.html)
CA (1) CA2193348C (cg-RX-API-DMAC7.html)
DE (1) DE69504198T2 (cg-RX-API-DMAC7.html)
DK (1) DK0767783T3 (cg-RX-API-DMAC7.html)
ES (1) ES2121389T3 (cg-RX-API-DMAC7.html)
FI (1) FI115135B (cg-RX-API-DMAC7.html)
HU (1) HUT75965A (cg-RX-API-DMAC7.html)
IL (1) IL114185A (cg-RX-API-DMAC7.html)
MX (1) MX9606654A (cg-RX-API-DMAC7.html)
NO (1) NO307458B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ287291A (cg-RX-API-DMAC7.html)
TW (1) TW442451B (cg-RX-API-DMAC7.html)
WO (1) WO1995035279A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA954947B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW541295B (en) * 1999-01-05 2003-07-11 Nippon Zoki Pharmaceutical Co A novel substituted alkylteraamine derivative for use as tachykinin antagonist
US6613801B2 (en) * 2000-05-30 2003-09-02 Transtech Pharma, Inc. Method for the synthesis of compounds of formula I and their uses thereof
JP2004523565A (ja) 2001-03-05 2004-08-05 トランス　テック　ファーマ，インコーポレイテッド 治療因子としてのベンゾイミダゾール誘導体
CN1494425B (zh) 2001-03-05 2011-12-07 特兰斯泰克制药公司 用作治疗剂的羧酰胺衍生物
ATE529110T1 (de) 2002-03-05 2011-11-15 Transtech Pharma Inc Mono- und bicyclische azolderivate die die interaktion von liganden mit rage hemmen
US20090263370A1 (en) * 2006-11-30 2009-10-22 Guoliang Tao Methods for treating tachykinin-mediated diseases with cholinesterase
TWI517850B (zh) 2009-09-30 2016-01-21 Ｖｔｖ治療有限責任公司 經取代之咪唑衍生物及其使用方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0394989A2 (en) * 1989-04-28 1990-10-31 Fujisawa Pharmaceutical Co., Ltd. Peptide compounds, process for preparation thereof and pharmaceutical composition comprising the same
WO1993001169A2 (en) * 1991-07-05 1993-01-21 Merck Sharp & Dohme Limited Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
WO1994004494A1 (en) * 1992-08-13 1994-03-03 Warner-Lambert Company Tachykinin antagonists

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0394989A2 (en) * 1989-04-28 1990-10-31 Fujisawa Pharmaceutical Co., Ltd. Peptide compounds, process for preparation thereof and pharmaceutical composition comprising the same
WO1993001169A2 (en) * 1991-07-05 1993-01-21 Merck Sharp & Dohme Limited Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
WO1994004494A1 (en) * 1992-08-13 1994-03-03 Warner-Lambert Company Tachykinin antagonists

Also Published As

Publication number Publication date
NO307458B1 (no) 2000-04-10
DK0767783T3 (da) 1999-05-25
FI115135B (fi) 2005-03-15
TW442451B (en) 2001-06-23
ATE169905T1 (de) 1998-09-15
JP3920916B2 (ja) 2007-05-30
NZ287291A (en) 1998-10-28
IL114185A (en) 1999-07-14
WO1995035279A1 (en) 1995-12-28
HU9603540D0 (en) 1997-02-28
DE69504198T2 (de) 1999-04-29
CA2193348C (en) 1999-08-24
NO965469L (no) 1997-02-19
AU2596195A (en) 1996-01-15
MX9606654A (es) 1997-12-31
CA2193348A1 (en) 1995-12-28
KR100371981B1 (ko) 2003-06-12
US5597845A (en) 1997-01-28
JPH10501551A (ja) 1998-02-10
EP0767783A1 (en) 1997-04-16
IL114185A0 (cg-RX-API-DMAC7.html) 1995-10-31
ZA954947B (en) 1996-01-31
ES2121389T3 (es) 1998-11-16
AU691619B2 (en) 1998-05-21
EP0767783B1 (en) 1998-08-19
CN1155883A (zh) 1997-07-30
NO965469D0 (no) 1996-12-19
FI965097L (fi) 1996-12-18
HUT75965A (en) 1997-05-28
FI965097A0 (fi) 1996-12-18
DE69504198D1 (de) 1998-09-24

Similar Documents

Publication Publication Date Title
CN1098255C (zh) 新的具有速激肽受体拮抗活性的取代的哌嗪衍生物
CN1072220C (zh) 作为神经激肽受体拮抗剂的1－苯甲酰基－2－(吲哚基－3－烷基)－哌嗪衍生物
CN1232507C (zh) 生长激素促分泌剂
CN1078889C (zh) 非肽类速激肽受体拮抗剂
CN1081635C (zh) 取代的吡咯烷 －3－基－烷基－哌啶
CN1094943C (zh) 诱导产生细胞素的尿烷类和尿素化合物
CN1111529C (zh) 作为神经激肽拮抗剂的哌嗪子基衍生物
CN1344160A (zh) 用作生长激素促分泌剂的杂环芳族化合物
CN1688548A (zh) 喹啉抗生素中间体的制备方法
CN1040986A (zh) 环烷基取代的戊二酰胺衍生物的制备
CN1918119A (zh) 双环酯类衍生物
CN1492852A (zh) 作为fsad的nep抑制剂的n-苯丙基环戊基取代的戊二酰胺衍生物
CN1279666A (zh) 新的npy拮抗剂
CN1119328C (zh) 作为nk1和nk2拮抗剂的酰氨基亚链烯基酰胺衍生物
CN1127488C (zh) 具有生长激素释放特性的化合物
CN1083429C (zh) 取代的烷基二胺衍生物和其作为速激肽拮抗剂的用途
CN1100032C (zh) 3,4－二取代的苯基乙醇氨基1,2,3,4,－四氢化萘甲酰胺衍生物
CN1665503A (zh) 杂芳烃甲酰胺作为多巴胺－d3配体用于治疗中枢神经系统疾病的用途
CN1501941A (zh) 化合物
CN1167710C (zh) 吡咯烷羰基氨基环状二硫化物
CN1675180A (zh) 吲哚、吲唑和氮茚衍生物
CN1662519A (zh) 新化合物及其作为甘氨酸转运抑制剂的用途
CN1218467A (zh) 新的含酰胺键的硫衍生物,它们的制备方法,它们作为药物的用途以及含有它们的药物组合物
CN1067068C (zh) 用作速激肽受体拮抗剂的杂环取代的哌嗪酮衍生物
CN1098259C (zh) 新的羧基取代的环状羧酰胺衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee